Compounds > clindamycin

clindamycin and Diabetic Feet

clindamycin has been researched along with Diabetic Feet in 19 studies

Research

Studies (19)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (31.58)	18.2507
2000's	4 (21.05)	29.6817
2010's	6 (31.58)	24.3611
2020's	3 (15.79)	2.80

Authors

Authors	Studies
Citron, DM; Fernandez, HT; Goldstein, EJ; Merriam, CV; Tyrrell, KL; Warren, YA	1
Bhattacharya, T; Chattopadhyay, D; Dey, S; Ghosh, A; Ghosh, S; Saha, K	1
Berkane, N; Bihan, H; Carbonnelle, E; Charbit, J; Cosson, E; Jaureguy, F; Jullien, V; Magréault, S	1
Donou, A; Kalantzi, S; Konsta, E; Loupa, CV; Meimeti, E; Voyatzoglou, ED	1
Mureithi, MW; Mutonga, DM; Ngugi, NN; Otieno, FCF	1
Kumar, A; Shahi, SK; Singh, VK	1
de Vries, MG; Ekkelenkamp, MB; Peters, EJ	1
Carvalho, J; da Silva, JR; Furtado, A; Pinho, R; Ponte, A; Silva, M	1
Akcaer, M; Coskun, O; Karakas, A; Sari, S; Tok, D	1
Gupta, SK; Kumar, A; Shahi, SK; Singh, SK; Singh, VK	1
Hörnlein, B; Irsigler, K; Kästenbauer, T; Sokol, G	1
Durand, ML; Ferraro, MJ; Walsh, SR	1
Paquet, P; Piérard, GE; Schaaf-Lafontaine, N	1
Lémb, DU	1
Ohl, CA; Paparello, S; Sullivan, N	1
Eliseev, OM	1
Finch, RG; Fletcher, EM; Jeffcoate, WJ; Lawn, S; Macfarlane, RM; Venkatesan, P	1
Diamantopoulos, EJ; Grigoriadou, M; Haritos, D; Margariti, G; Paniara, O; Raptis, SA; Yfandi, G	1
Benedetti, P; Bonato, M; de Lalla, F; Erle, G; Furlan, F; Lora, L; Pellizzer, G; Presi, S; Strazzabosco, M	1

Reviews

1 review(s) available for clindamycin and Diabetic Feet

Article	Year
[The use of clindamycin in therapeutic practice]. Terapevticheskii arkhiv, 1993, Volume: 65, Issue:8 Topics: Acquired Immunodeficiency Syndrome; Clindamycin; Diabetic Foot; Endocarditis; Humans; Lung Abscess; Osteomyelitis; Pharyngitis; Pneumonia; Tonsillitis	1993

Trials

3 trial(s) available for clindamycin and Diabetic Feet

Article	Year
Evaluation of granulocyte-colony stimulating factor (Filgrastim) in infected diabetic foot ulcers. Diabetologia, 2003, Volume: 46, Issue:1 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Bed Rest; Cellulitis; Ciprofloxacin; Clindamycin; Diabetic Foot; Drug Therapy, Combination; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Infections; Injections, Intravenous; Male; Middle Aged; Recombinant Proteins; Treatment Outcome	2003
Management and outcome of severe diabetic foot infections. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 1998, Volume: 106, Issue:4 Topics: Aged; Anti-Bacterial Agents; Anti-Infective Agents; Blood Glucose; Ciprofloxacin; Clindamycin; Diabetic Foot; Female; Humans; Leg; Male; Microbial Sensitivity Tests; Middle Aged; Regional Blood Flow; Treatment Outcome; Wound Healing	1998
Deep tissue biopsy vs. superficial swab culture monitoring in the microbiological assessment of limb-threatening diabetic foot infection. Diabetic medicine : a journal of the British Diabetic Association, 2001, Volume: 18, Issue:10 Topics: Adult; Bacterial Infections; Biopsy; Ciprofloxacin; Clindamycin; Corynebacterium; Diabetic Foot; Drug Therapy, Combination; Enterococcus; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Reproducibility of Results; Sensitivity and Specificity; Specimen Handling; Staphylococcus	2001

Other Studies

15 other study(ies) available for clindamycin and Diabetic Feet

Article	Year
In vitro activities of doripenem and six comparator drugs against 423 aerobic and anaerobic bacterial isolates from infected diabetic foot wounds. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Carbapenems; Diabetic Foot; Doripenem; Humans; Microbial Sensitivity Tests	2008
Ameliorative effects of clindamycin - nanoceria conjugate: A ROS responsive smart drug delivery system for diabetic wound healing study. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS), 2023, Volume: 75 Topics: Animals; Clindamycin; Diabetes Mellitus, Experimental; Diabetic Foot; Drug Delivery Systems; Rats; Reactive Oxygen Species	2023
Usefulness of Therapeutic Drug Monitoring to Manage Clindamycin-Rifampicin Interaction in a Patient with Diabetic Foot Osteomyelitis. Therapeutic drug monitoring, 2023, 10-01, Volume: 45, Issue:5 Topics: Clindamycin; Diabetes Mellitus; Diabetic Foot; Drug Monitoring; Humans; Osteomyelitis; Rifampin	2023
Photosensitivity During Quinolone Therapy in Diabetic Foot Patients May Falsely Indicate Treatment Failure. The international journal of lower extremity wounds, 2023, Volume: 22, Issue:1 Topics: Aged; Clindamycin; Diabetes Mellitus, Type 2; Diabetic Foot; Humans; Male; Middle Aged; Osteomyelitis; Quinolones; Treatment Failure; Ulcer	2023
Bacterial isolation and antibiotic susceptibility from diabetic foot ulcers in Kenya using microbiological tests and comparison with RT-PCR in detection of S. aureus and MRSA. BMC research notes, 2019, Apr-29, Volume: 12, Issue:1 Topics: Anti-Bacterial Agents; Bacterial Infections; Bacterial Typing Techniques; Cephalosporins; Clindamycin; Cross-Sectional Studies; Diabetic Foot; Drug Resistance, Multiple, Bacterial; Escherichia coli; Humans; Kenya; Klebsiella pneumoniae; Macrolides; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillins; Proteus mirabilis; Pseudomonas aeruginosa; Real-Time Polymerase Chain Reaction; Staphylococcus aureus; Sulfanilamides	2019
Detection of Escherichia coli and associated β-lactamases genes from diabetic foot ulcers by multiplex PCR and molecular modeling and docking of SHV-1, TEM-1, and OXA-1 β-lactamases with clindamycin and piperacillin-tazobactam. PloS one, 2013, Volume: 8, Issue:7 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; beta-Lactamases; beta-Lactams; Clindamycin; Diabetic Foot; Escherichia coli; Escherichia coli Infections; Gene Expression; Humans; Microbial Sensitivity Tests; Molecular Docking Simulation; Multiplex Polymerase Chain Reaction; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Structural Homology, Protein; Structure-Activity Relationship	2013
Are clindamycin and ciprofloxacin appropriate for the empirical treatment of diabetic foot infections? European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2014, Volume: 33, Issue:3 Topics: Aged; Amputation, Surgical; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Clindamycin; Cohort Studies; Diabetic Foot; Female; Humans; Male; Middle Aged; Retrospective Studies; Wound Healing	2014
Esophagitis dissecans superficialis associated with severe clindamycin toxicity. Journal of gastrointestinal and liver diseases : JGLD, 2014, Volume: 23, Issue:4 Topics: Adult; Anti-Bacterial Agents; Biopsy; Clindamycin; Diabetic Foot; Esophagitis; Esophagoscopy; Esophagus; Female; Humans; Mucous Membrane; Proton Pump Inhibitors; Treatment Outcome	2014
Eosinophilic pneumonia: Daptomycin-induced lung complication. Medecine et maladies infectieuses, 2016, Volume: 46, Issue:3 Topics: Abscess; Amputation Stumps; Anti-Bacterial Agents; Ciprofloxacin; Clindamycin; Combined Modality Therapy; Daptomycin; Debridement; Diabetic Foot; Drainage; Drug Substitution; Drug Therapy, Combination; Humans; Male; Middle Aged; Pulmonary Eosinophilia; Soft Tissue Infections; Surgical Wound Infection; Tomography, X-Ray Computed	2016
Interaction of dihydrofolate reductase and aminoglycoside adenyltransferase enzyme from Klebsiella pneumoniae multidrug resistant strain DF12SA with clindamycin: a molecular modelling and docking study. Journal of molecular modeling, 2013, Volume: 19, Issue:3 Topics: Amino Acid Sequence; Anti-Bacterial Agents; Base Sequence; Catalytic Domain; Clindamycin; Diabetic Foot; Drug Design; Drug Resistance, Multiple, Bacterial; Humans; Integrons; Klebsiella pneumoniae; Microbial Sensitivity Tests; Models, Molecular; Molecular Docking Simulation; Nucleotidyltransferases; Protein Structure, Tertiary; Restriction Mapping; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Tetrahydrofolate Dehydrogenase	2013
Clindamycin-resistant Streptococcus pyogenes: report of a case. Diagnostic microbiology and infectious disease, 2004, Volume: 49, Issue:3 Topics: Adult; Clindamycin; Diabetic Foot; Drug Resistance, Bacterial; Drug Therapy, Combination; Fasciitis, Necrotizing; Female; Follow-Up Studies; Humans; Microbial Sensitivity Tests; Risk Assessment; Severity of Illness Index; Streptococcus pyogenes; Treatment Outcome; Wound Healing	2004
Toxic epidermal necrolysis following clindamycin treatment. The British journal of dermatology, 1995, Volume: 132, Issue:4 Topics: Clindamycin; Diabetic Foot; Humans; Lymphocyte Activation; Male; Middle Aged; Stevens-Johnson Syndrome	1995
[Treatment of diabetic foot gangrene]. Khirurgiia, 1994, Issue:8 Topics: Animals; Bacteria, Anaerobic; Bacterial Infections; Clindamycin; Diabetic Foot; Gangrene; Humans; Microbial Sensitivity Tests; Models, Biological; Rabbits	1994
Streptococcus sanguis bacteremia during ciprofloxacin therapy of a diabetic foot ulcer. The American journal of medicine, 1994, Volume: 96, Issue:5 Topics: Bacteremia; Ciprofloxacin; Clindamycin; Diabetes Mellitus, Type 1; Diabetic Foot; Drug Resistance, Microbial; Humans; Male; Middle Aged; Streptococcal Infections; Streptococcus sanguis	1994
Conservative management of osteomyelitis in the feet of diabetic patients. Diabetic medicine : a journal of the British Diabetic Association, 1997, Volume: 14, Issue:6 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Bone and Bones; Clindamycin; Diabetic Foot; Disease Management; Female; Humans; Male; Middle Aged; Osteomyelitis; Retrospective Studies; Soft Tissue Infections; Toes; Treatment Outcome	1997